HRMY - Wolf Popper LLP Continues its Investigation on Behalf of Investors in Harmony Biosciences Holdings Inc. | Benzinga
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is continuing to investigate potential securities fraud claims on behalf of purchasers of Harmony Biosciences Holdings, Inc. ("Harmony") common stock (NASDAQ:HRMY).
Harmony is a commercial and clinical stage drug company that focuses on therapies for patients with rare neurological diseases.
Before the market opened on March 28, 2023, Scorpion Capital published a short seller report headlined "The Latest Price-Gouging Ploy By The Grifter Who Inspired Convicted Felon Martin Shkreli, But This Time People Have Blood On Their Hands: A $175,000 Per Year Drug With Alarming Toxicity ...